Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marie-France Hivert, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Marie-France Hivert and Edward Horton.
Marie-France Hivert
Connection Strength
0.792
Edward Horton
  1. Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants. Diabetes. 2016 Feb; 65(2):520-6.
    View in: PubMed
    Score: 0.160
  2. Temporal trends of concentrations of per- and polyfluoroalkyl substances among adults with overweight and obesity in the United States: Results from the Diabetes Prevention Program and NHANES. Environ Int. 2021 12; 157:106789.
    View in: PubMed
    Score: 0.059
  3. Per- and polyfluoroalkyl substances and calcifications of the coronary and aortic arteries in adults with prediabetes: Results from the diabetes prevention program outcomes study. Environ Int. 2021 06; 151:106446.
    View in: PubMed
    Score: 0.058
  4. Per- and polyfluoroalkyl substances and kidney function: Follow-up results from the Diabetes Prevention Program trial. Environ Int. 2021 03; 148:106375.
    View in: PubMed
    Score: 0.057
  5. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study. Environ Int. 2020 04; 137:105573.
    View in: PubMed
    Score: 0.054
  6. Dietary characteristics associated with plasma concentrations of per- and polyfluoroalkyl substances among adults with pre-diabetes: Cross-sectional results from the Diabetes Prevention Program Trial. Environ Int. 2020 04; 137:105217.
    View in: PubMed
    Score: 0.054
  7. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019 Jul 31.
    View in: PubMed
    Score: 0.052
  8. Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease. Diabetes Care. 2019 09; 42(9):1824-1832.
    View in: PubMed
    Score: 0.052
  9. A Polygenic Lipodystrophy Genetic Risk Score Characterizes Risk Independent of BMI in the Diabetes Prevention Program. J Endocr Soc. 2019 Sep 01; 3(9):1663-1677.
    View in: PubMed
    Score: 0.051
  10. Dietary Characteristics and Exposure to Per- and Polyfluoroalkyl Substances Among Pre-diabetic Adults in Diabetes Prevention Program (OR17-06-19). Curr Dev Nutr. 2019 Jun; 3(Suppl 1).
    View in: PubMed
    Score: 0.051
  11. Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study. Environ Int. 2019 08; 129:343-353.
    View in: PubMed
    Score: 0.051
  12. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity. JAMA Netw Open. 2018 08 03; 1(4):e181493.
    View in: PubMed
    Score: 0.048
  13. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial. Environ Health Perspect. 2017 10 02; 125(10):107001.
    View in: PubMed
    Score: 0.046
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.